this post was submitted on 22 Mar 2026
16 points (80.8% liked)
news
795 readers
651 users here now
A lightweight news hub to help decentralize the fediverse load: mirror and discuss headlines here so the giant instance communities aren’t a single choke-point.
Rules:
- Recent news articles only (past 30 days)
- Title must match the headline or neutrally describe the content
- Avoid duplicates & spam (search before posting; batch minor updates).
- Be civil; no hate or personal attacks.
- No link shorteners
- No entire article in the post body
founded 7 months ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
I think it's well understood that people who produce glp1 correctly can still be obese and need weight loss and these drugs help with that. That's the whole point of the drug. To provide more glp1 than is needed to lose weight easily.
or they cause gastrointestinal conditions in these people, resulting in weight loss (and malnutrition) that is a symptom of the new problem rather than the drug itself. If you don't have GLP-1 problems, then GLP-1 is not a solution, and dieting will be effective.
The entire point of glp1 is to prescribe when dieting isn't effective.
You mean when people refuse to change their diets and restrict caloric intake.
Have you read any of the other comments here? People aren't just "refusing" to change their diets. I'm not going to type my response again but see my comment here. Or maybe this comment by someone else. Or maybe this one. The point is that when 20+% of the population are afflicted with something, it's not a problem of them "refusing" to fix it themselves. It's a systemic issue.